FDA considering accelerated approval of new Alzheimer?s drug

Name: FDA considering accelerated approval of new Alzheimer?s drug
Uploaded: 2023-01-05T00:47:03Z
Description: The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer?s disease.� The FDA is expected to reach a decision by Friday, January 6.

The FDA is considering accelerated approval of a new drug shown to attack amyloid plaque in the human brain, a contributing cause of cognitive dysfunction in dementia and Alzheimer?s disease.� The FDA is expected to reach a decision by Friday, January 6.

Posted January 4, 2023 6:47pm CST